We found significantly lower INPP4B expression in metastatic melanomas compared to primary lesions (Figure 1A) corroborating earlier findings that loss of INPP4B expression may modulate the metastatic potential of tumors [9]. This evidence concerns the gene INPP4B and melanoma.